Nutrison Protein Plus

Indications

For use in the dietary management of:

• Disease-related malnutrition with moderate metabolic stress.
• Conditions with increased protein requirements e.g. post-surgery, infections, cancer, trauma.

Important Notice

• Not for parenteral use.
• Not suitable for patients with galactosaemia.
• Not suitable for patients with cow’s milk protein allergy.
• Not suitable for infants under 1 year of age.
• Use with caution in children aged 1-6 years of age.
• Use with caution in individuals with a seafood allergy.

Direction for Use

• Use at room temperature.
• Shake well before use.
• Handle aseptically to ensure product remains sterile.
• Usage to be determined by a healthcare professional.

Storage

• Store in a cool, dry place.
• Once opened, store in the refrigerator.
• Discard unused contents after 24 hours.

Order Information

Contact Nutricia Customer Care 1800 889 480

Ingredients

Full ingredients list and nutritional information available on Factsheet.

Allergen & Cultural Information

• Contains: cow’s milk protein, soy, fish oil.
• Does not contain: wheat, egg, nuts*, lupins.
• Halal certified.
• No Kosher forbidden ingredients.
• No gluten containing ingredients. No detectable gluten when tested to a sensitivity level of less than 5 parts per million (<5 ppm i.e. <5mg/kg).
• Low lactose (lactose <2g/100g).

References

1. Hurt RT, McClave SA, Martindale RG, et al. Summary Points and Consensus Recommendations From the International Protein Summit. Nutrition in Clinical Practice. 2017;32:142S–151S.
2. World Health Organization. Protein and amino acid requirements in human nutrition: report of a joint FAO/WHO/UNU expert consultation. 2007; WHO technical report series ; no. 935.
3. Kuyumcu S, Menne D, Curcic J, et al. Noncoagulating enteral formula can empty faster from the stomach: A double-blind, randomized crossover trial using magnetic resonance imaging. Journal of Parenteral and Enteral Nutrition. 2015;39:544-551.
4. van den Braak CC, Klebach M, Abrahamse E, et al. A novel protein mixture containing vegetable proteins renders enteral nutrition products non-coagulating after in vitro gastric digestion. Clinical Nutrition. 2013;32:765-771.
5. Klebach M, Hofman Z, Bluemel S, et al. Effect of protein type in enteral nutrition formulas on coagulation in the stomach in vivo: Post hoc analyses of a randomized controlled trial with MRI. Abstract presented at Clinical Nutrition Week, January 16–19; Austin, Tx. Journal of Parenteral and Enteral Nutrition. 2016;40:134(21).
6. Luttikhold J, van Norren K, Rijna H, et al. Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial. Am J Clin Nutr. 2016;103:435–43.
7. Abrahamse E, van der Lee S, van den Braak S, et al. Gastric non-coagulation of enteral tube feed yields faster gastric emptying of protein in a dynamic in vitro model. Abstract presented at 34th ESPEN Congress. Sept 8-11; Barcelona, Spain. Clinical Nutrition Supplements. 2012;7:PP239(119).
8. Liu J, Klebach M, Abrahamse E, et al. Specific protein mixture reduces coagulation: An in vitro stomach model study mimicking a gastric condition in critically ill patients. Poster presented at 38th ESPEN Congress. 17-20 September; Copenhagen, Denmark. Clinical Nutrition. 2016;35:MON-P182 (S220).

Additional Information

^ In accordance with Australia New Zealand Food Standards Code – Standard 2.9.5